The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder

키워드

참고문헌 (42)

1. Morgan VA, "The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders", Bipolar Disord, 7, pp.326~337 (2005)[DOI]
2. Sun X, "Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder", J Psychiatry Neurosci, 31, pp.189~196 (2006)
3. MacDonald ML, "Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder", Bipolar Disord, 8, pp.255~264 (2006)[DOI]
4. Iwamoto K, "Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis", Hum Mol Genet, 14, pp.241~253 (2005)[DOI]
5. Konradi C, "Molecular evidence for mitochondrial dysfunction in bipolar disorder", Arch Gen Psychiatry, 61, pp.300~308 (2004)[DOI]
6. Adam-Vizi V, "Bioenergetics and the formation of mitochondrial reactive oxygen species", Trends Pharmacol Sci, 27, pp.639~645 (2006)[DOI]
7. Takuma K, "Astrocyte apoptosis: implications for neuroprotection", Prog Neurobiol, 72, pp.111~127 (2004)[DOI]
8. Brown NC, "An updated meta-analysis of oxidative stress markers in bipolar disorder", Psychiatry Res, 218, pp.61~68 (2014)[DOI]
9. Serrano F, "Reactive oxygen species and synaptic plasticity in the aging hippocampus", Ageing Res Rev, 3, pp.431~443 (2004)[DOI]
10. Kunz M, "Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1677~1681 (2008)[DOI]
11. Berk M, "Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors", Neurosci Biobehav Rev, 35, pp.804~817 (2011)[DOI]
12. Kuloglu M, "Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder", Cell Biochem Funct, 20, pp.171~175 (2002)[DOI]
13. Ranjekar PK, "Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients", Psychiatry Res, 121, pp.109~122 (2003)[DOI]
14. Erdem M, "Bipolar disorder and oxidative stress", J Mood Disord, 4, pp.70~79 (2014)[DOI]
15. Ozcan ME, "Antioxidant enzyme activities and oxidative stress in affective disorders", Int Clin Psychopharmacol, 19, pp.89~95 (2004)[DOI]
16. Zarate CA, "Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder", Biol Psychiatry, 59, pp.1006~1020 (2006)[DOI]
17. Akarsu S, "Mitochondrial complex I and III mRNA levels in bipolar disorder", J Affect Disord, 184, pp.160~163 (2015)[DOI]
18. Machado-Vieira R, "Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects", Neurosci Lett, 421, pp.33~36 (2007)[DOI]
19. Young RC, "A rating scale for mania: reliability, validity and sensitivity", Br J Psychiatry, 133, pp.429~435 (1978)[DOI]
20. Karadag F, "Reliability and validity of Turkish translation of young mania rating scale", Turk Psikiyatri Derg, 13, pp.107~114 (2002)
21. Erel O, "A novel automated method to measure total antioxidant response against potent free radical reactions", Clin Biochem, 37, pp.112~119 (2004)[DOI]
22. Yumru M, "Oxidative imbalance in bipolar disorder subtypes: a comparative study", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.1070~1074 (2009)[DOI]
23. Erel O, "A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation", Clin Biochem, 37, pp.277~285 (2004)[DOI]
24. Prior RL, "In vivo total antioxidant capacity: comparison of different analytical methods", Free Radic Biol Med, 27, pp.1173~1181 (1999)[DOI]
25. Erel O, "A new automated colorimetric method for measuring total oxidant status", Clin Biochem, 38, pp.1103~1111 (2005)[DOI]
26. Kosecik M, "Increased oxidative stress in children exposed to passive smoking", Int J Cardiol, 100, pp.61~64 (2005)[DOI]
27. Andreazza AC, "Oxidative stress markers in bipolar disorder: a metaanalysis", J Affect Disord, 111, pp.135~144 (2008)[DOI]
28. Savas HA, "Possible role of nitric oxide and adrenomedullin in bipolar disorder", Neuropsychobiology, 45, pp.57~61 (2002)[DOI]
29. Khairova R, "Effects of lithium on oxidative stress parameters in healthy subjects", Mol Med Report, 5, pp.680~682 (2012)
30. Andreazza AC, "Serum S100B and antioxidant enzymes in bipolar patients", J Psychiatr Res, 41, pp.523~529 (2007)[DOI]
31. Savas HA, "Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes", World J Biol Psychiatry, 7, pp.51~55 (2006)[DOI]
32. Gergerlioglu HS, "Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.697~702 (2007)[DOI]
33. Frey BN, "Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania", J Psychiatry Neurosci, 31, pp.326~332 (2006)
34. Wang JF, "Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells", Neuroscience, 116, pp.485~489 (2003)[DOI]
35. Shao L, "Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells", Biol Psychiatry, 58, pp.879~884 (2005)[DOI]
36. Chen B, "Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus", Biol Psychiatry, 48, pp.658~664 (2000)[DOI]
37. Shao L, "Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells", Life Sci, 78, pp.1317~1323 (2006)[DOI]
38. Chen G, "The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS", J Neurochem, 72, pp.879~882 (1999)[DOI]
39. Cui J, "Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate", Neuroscience, 144, pp.1447~1453 (2007)[DOI]
40. Lai JS, "Cytoprotection by lithium and valproate varies between cell types and cellular stresses", Eur J Pharmacol, 539, pp.18~26 (2006)[DOI]
41. Chang YC, "Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex", Neurochem Res, 34, pp.536~541 (2009)[DOI]
42. Yasuda S, "The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons", Mol Psychiatry, 14, pp.51~59 (2009)[DOI]

관련 논문AI추천